Transrectal ultrasound features and biopsy outcomes of transition PI-RADS 5 - Jae Hoon Chung, Byung Kwan Park, 2022
PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association
PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - ScienceDirect
PSA Testing | ZERO Prostate Cancer
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml | PLOS ONE
Prostate-specific antigen - Wikipedia
The mean PSA level (ng/mL) by the number of alleles across the 4 PSA-SNPs. | Download Table
Understanding PSA Levels & The PSA Test | HALO Precision Diagnostics
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
A 68-year-old male presenting with an elevated PSA level of 5 ng/mL was... | Download Scientific Diagram
Supplemental-Table 1 Lesion detection rate n (%) Overall lesion detection rate 194/245 (79.2%) At PSA < 0.5 ng/mL 27/56 (48.2
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
International Braz J Urol ::
Elevated PSA: Noncancerous causes and considerations
Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements | Scientific Reports
JCM | Free Full-Text | New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions
Understanding PSA and other prostate cancer screenings | Prolaris
Understanding PSA and other prostate cancer screenings | Prolaris
